35,927 results match your criteria elevation myocardial


Interrupted Incision Fasciotomy for Acute Compartment Syndrome After Extracorporeal Membrane Oxygenation: Surgical Technique with a Report of Two Cases.

Orthop Surg 2021 Dec 6. Epub 2021 Dec 6.

Department of Orthopaedic Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Background: After extracorporeal membrane oxygenation (ECMO), acute compartment syndrome (ACS) can develop because of limb ischemia or reperfusion. The standard treatment for ACS is emergency fasciotomy. We introduced an interrupted incision technique instead of a long double-incision to reduce blood loss and subsequent hypovolemia in ECMO patients. Read More

View Article and Full-Text PDF
December 2021

Use of the Thrombolysis in Myocardial Infarction Risk Index for Elderly Patients With ST-Segment Elevation Myocardial Infarction.

Front Cardiovasc Med 2021 19;8:743678. Epub 2021 Nov 19.

Division of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.

Thrombolysis in Myocardial Infarction (TIMI) Risk Index (TRI) is a simple risk assessment tool for patients with ST-segment elevation myocardial infarction (STEMI). However, its applicability to elderly patients with STEMI undergoing percutaneous coronary intervention (PCI) is uncertain. This was a retrospective analysis of elderly (≥60 years) patients who underwent PCI for STEMI from January 2010 to April 2016. Read More

View Article and Full-Text PDF
November 2021

Visceral Adiposity Index Plays an Important Role in Prognostic Prediction in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome and Type 2 Diabetes Mellitus Undergoing Percutaneous Coronary Intervention.

Front Cardiovasc Med 2021 18;8:735637. Epub 2021 Nov 18.

Clinical Center for Coronary Heart Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Department of Cardiology, Beijing Anzhen Hospital, Beijing Institute of Heart Lung and Blood Vessel Disease, Capital Medical University, Beijing, China.

Visceral adiposity index (VAI), a surrogate marker of adiposity and insulin resistance, has been demonstrated to be significantly related to cardiovascular disease. It remains indistinct whether VAI predicts adverse prognosis after percutaneous coronary intervention (PCI) for patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) and type 2 diabetes mellitus (T2DM). A total of 798 participants who met the enrollment criteria were finally brought into this study. Read More

View Article and Full-Text PDF
November 2021

Fibroblast Growth Factor-23-Klotho Axis in Cardiorenal Syndrome: Mediators and Potential Therapeutic Targets.

Front Physiol 2021 15;12:775029. Epub 2021 Nov 15.

Cardiorenal Translational Laboratory, Institute of Research i + 12, Hospital Universitario 12 de Octubre, Madrid, Spain.

Cardiorenal syndrome (CRS) is a complex disorder that refers to the category of acute or chronic kidney diseases that induce cardiovascular disease, and inversely, acute or chronic heart diseases that provoke kidney dysfunction. There is a close relationship between renal and cardiovascular disease, possibly due to the presence of common risk factors for both diseases. Thus, it is well known that renal diseases are associated with increased risk of developing cardiovascular disease, suffering cardiac events and even mortality, which is aggravated in those patients with end-stage renal disease or who are undergoing dialysis. Read More

View Article and Full-Text PDF
November 2021

Coil Embolization for Coronary Artery Perforation: A Retrospective Analysis of 110 Patients.

J Interv Cardiol 2021 12;2021:9022326. Epub 2021 Nov 12.

Department of Cardiology, Asia Medical Group, Sapporo Heart Center, Sapporo Cardio Vascular Clinic, Sapporo, Japan.

Objective: Coil embolization (CE) for coronary artery perforation (CAP) has not been thoroughly evaluated. This study aimed to evaluate the extent of myocardial damage and impact on cardiac function after CE for CAP.

Methods: A total of 110 consecutive patients treated with CE for CAP were retrospectively identified. Read More

View Article and Full-Text PDF
November 2021

Impact of Renal Insufficiency on Prognosis of Patients with Acute Coronary Syndrome.

Int J Gen Med 2021 26;14:8919-8927. Epub 2021 Nov 26.

Department of Cardiology, Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu, Chengdu, Sichuan, People's Republic of China.

Purpose: Chronic kidney disease (CKD) is common in patients admitted with acute coronary syndrome (ACS), and it is associated with poor outcomes. However, data are limited. Hence, we examined the long-term prognostic significance of estimated glomerular filtration rate (eGFR) among Chinese patients hospitalized with ACS. Read More

View Article and Full-Text PDF
November 2021

Thromboembolic ST elevation myocardial infarction due to a large coronary aneurysm: Role of apixaban.

Anatol J Cardiol 2021 Dec;25(12):922-923

Department of UOSD Emergency Cardiology, UOC Cardiologia, Sandro Pertini Hospital; Rome-Italy.

View Article and Full-Text PDF
December 2021

Invasive Management of Acute Myocardial Infarctions During the Initial Wave of the COVID-19 Pandemic.

J Invasive Cardiol 2021 Dec 5. Epub 2021 Dec 5.

The Leon H. Charney Division of Cardiology, NYU Langone Health, NYU School of Medicine, 423 East 23rd Street, Room 12020-W, New York, NY 10010 USA.

Background: The initial wave of the coronavirus disease 2019 (COVID-19) pandemic resulted in an influx of patients with acute viral illness and profound changes in healthcare delivery in New York City. The impact of this pandemic on the presentation and invasive management of acute myocardial infarction (MI) is not well described.

Methods: This single-center retrospective study compared patients with MI who underwent invasive coronary angiography at New York University from March-April 2020, during the peak of the first wave of the pandemic, with those presenting in March-April 2019. Read More

View Article and Full-Text PDF
December 2021

Pericardial and myocardial involvement after SARS-CoV-2 infection: a cross-sectional descriptive study in healthcare workers.

Rev Esp Cardiol (Engl Ed) 2021 Nov 5. Epub 2021 Nov 5.

Servicio de Cardiología, Hospital Universitario de Salamanca, Salamanca, Spain; Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV), Spain; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain; Facultad de Medicina, Universidad de Salamanca, Salamanca, Spain. Electronic address:

Introduction And Objectives: The cardiac sequelae of SARS-CoV-2 infection are still poorly documented. We conducted a cross-sectional study in healthcare workers to report evidence of pericardial and myocardial involvement after SARS-CoV-2 infection.

Methods: We studied 139 healthcare workers with confirmed past SARS-CoV-2 infection. Read More

View Article and Full-Text PDF
November 2021

Heparin still one of the most important reperfusion therapies for ST-elevation myocardial infarction in out-of-hospital settings.

Authors:
Abdo Khoury

Eur Heart J Acute Cardiovasc Care 2021 Dec 3. Epub 2021 Dec 3.

Department of Emergency Medicine and Critical Care, Besançon University Hospital, 25030 Besançon CEDEX, Boulevard Fleming, France.

View Article and Full-Text PDF
December 2021

Statins for primary prevention among elderly men and women.

Cardiovasc Res 2021 Dec 1. Epub 2021 Dec 1.

Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.

Aims: We undertook a propensity match-weighted cohort study to investigate whether statin treatment recommendations for statins translate into improved cardiovascular (CV) outcomes in the current routine clinical care of the elderly.

Methods And Results: We included in our analysis (ISACS Archives -NCT04008173) a total of 5,619 Caucasian patients with no known prior history of CV disease who presented to hospital with a first manifestation of CV disease with age of 65 years or older. The risk of ST segment elevation myocardial infarction (STEMI) was much lower in statin users than in nonusers in both patients aged 65 to 75 years (14. Read More

View Article and Full-Text PDF
December 2021

Cardiogenic Shock Complicating ST-Segment Elevation Myocardial Infarction: An 18-Year Analysis of Temporal Trends, Epidemiology, Management and Outcomes.

Shock 2021 Dec 3. Epub 2021 Dec 3.

Section of Cardiovascular Medicine, Department of Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina Department of Medicine, University of Miami / JFK Medical Center Palm Beach Regional GME Consortium, Miami, Florida Department of Primary Care Internal Medicine, Wake Forest Baptist Health, High Point, North Carolina Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota Division of Cardiovascular Medicine, Department of Medicine, Saint Joseph University Medical Center, Paterson, New Jersey Division of Cardiovascular Medicine, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut.

Background: There are limited data on the temporal trends, incidence, and outcomes of ST-segment-elevation myocardial infarction-cardiogenic shock (STEMI-CS).

Methods: Adult (>18 years) STEMI-CS admissions were identified using the National Inpatient Sample (2000-2017) and classified by tertiles of admission year (2000-2005, 2006-2011, 2012-2017). Outcomes of interest included temporal trends, acute organ failure, cardiac procedures, in-hospital mortality, hospitalization costs, and length of stay. Read More

View Article and Full-Text PDF
December 2021

Instantaneous wave-free ratio for guiding treatment of nonculprit lesions in patients with acute coronary syndrome: A retrospective study.

Catheter Cardiovasc Interv 2021 Dec 4. Epub 2021 Dec 4.

Reina Sofía Hospital, Department of Cardiology, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), University of Córdoba, Córdoba, Spain.

Background: The aim of this study was to analyze the feasibility of a physiological coronary evaluation with the instantaneous wave-free ratio (iFR) of nonculprit lesions in patients with acute coronary syndrome (ACS) successfully revascularized.

Methods: A multicenter registry including patients of four high-volume PCI centers with ACS and underwent successful revascularization of the culprit vessel and had other nonculprit lesions that were physiologically evaluated with the iFR between January 2017 and December 2019. The primary endpoint was a composite of cardiac death, nonfatal myocardial infarction, probable or definitive stent thrombosis and new revascularization (MACEs). Read More

View Article and Full-Text PDF
December 2021

A potential diagnostic pitfall in ST elevation: Acute pulmonary embolism or ST-segment elevation myocardial infarction.

Ann Noninvasive Electrocardiol 2021 Dec 3:e12928. Epub 2021 Dec 3.

Department of Cardiology, Binzhou Medical University Hospital, Binzhou City, Shandong, China.

The diagnosis of acute pulmonary embolism (APE) is a great challenge for physicians due to its nonspecific symptoms, and often missed or misdiagnosed as acute coronary syndrome. Electrocardiographic (ECG) abnormalities are seen in majority of patients with APE. Recently, APE with ST-segment elevation (STE) in leads V -V /V , mimicking ST-segment elevation myocardial infarction (STEMI), has been described. Read More

View Article and Full-Text PDF
December 2021

Determinants of long-term dual antiplatelet therapy use in post myocardial infarction patients: Insights from the TIGRIS registry.

J Cardiol 2021 Nov 29. Epub 2021 Nov 29.

St Michael's Hospital, University of Toronto, Toronto, Canada. Electronic address:

Background: Patterns of dual antiplatelet therapy (DAPT) use beyond 1 year post-myocardial infarction (MI) have not been well studied.

Methods: TIGRIS (NCT01866904) was a prospective, multi-center (369 centers in 24 countries), observational study of patients 1 to 3 years post-MI. We sought to identify the prevalence and determinants of DAPT use ≥1 year post-MI in patients enrolled in TIGRIS. Read More

View Article and Full-Text PDF
November 2021

Demographic and Regional Trends of Mortality in Patients With ST-Elevation Myocardial Infarction in the United States, 1999 to 2019.

Am J Cardiol 2021 Nov 29. Epub 2021 Nov 29.

Division of Cardiovascular Medicine, University of Toledo Medical Center, Toledo, Ohio. Electronic address:

ST-elevation myocardial infarction (STEMI)-related mortality has been decreasing within the United States because of improvements in management and preventive efforts; however, persistent disparities in demographic subsets such as race may exist. In this study, the nationwide trends in mortality related to STEMI in adults in the United States from 1999 to 2019 are described. Trends in mortality related to STEMI were assessed through a cross-sectional analysis of the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research database. Read More

View Article and Full-Text PDF
November 2021

COVID-19 Infection and Myocarditis: A State-of-the-Art Systematic Review.

J Prim Care Community Health 2021 Jan-Dec;12:21501327211056800

King George Medical University, Lucknow, India.

Background: COVID-19 was initially considered to be a respiratory illness, but current findings suggest that SARS-CoV-2 is increasingly expressed in cardiac myocytes as well. COVID-19 may lead to cardiovascular injuries, resulting in myocarditis, with inflammation of the heart muscle.

Objective: This systematic review collates current evidence about demographics, symptomatology, diagnostic, and clinical outcomes of COVID-19 infected patients with myocarditis. Read More

View Article and Full-Text PDF
December 2021

Longitudinal Changes in Left Ventricular Blood Flow Kinetic Energy After Myocardial Infarction: Predictive Relevance for Cardiac Remodeling.

J Magn Reson Imaging 2021 Dec 2. Epub 2021 Dec 2.

LICAMM, Department of Biomedical Imaging Sciences, University of Leeds, Leeds, UK.

Background: Four-dimensional (4D) flow cardiac magnetic resonance (cardiac MR) imaging provides quantification of intracavity left ventricular (LV) flow kinetic energy (KE) parameters in three dimensions. ST-elevation myocardial infarction (STEMI) patients have been shown to have altered intracardiac blood flow compared to controls; however, how 4D flow parameters change over time has not been explored previously.

Purpose: Measure longitudinal changes in intraventricular flow post-STEMI and ascertain its predictive relevance of long-term cardiac remodeling. Read More

View Article and Full-Text PDF
December 2021

ST Depression in the Setting of Subarachnoid Hemorrhage.

Cureus 2021 Oct 25;13(10):e19030. Epub 2021 Oct 25.

Cardiology, MercyOne North Iowa Medical Center, Mason City, USA.

We present a case report of a patient presenting with subarachnoid hemorrhage whose electrocardiogram (ECG) mimicked non-ST-elevation myocardial infarction. A 36-year-old male with a past medical history of resistant hypertension, previous severe acute respiratory syndrome coronavirus 2 infection, and alcohol abuse presented to the hospital after cardiac arrest. He was taken to the catheterization lab upon arrival and was found to have an unremarkable coronary angiogram. Read More

View Article and Full-Text PDF
October 2021

Impact of the SARS-CoV-2 Pandemic on Primary Percutaneous Coronary Intervention for Patients with ST-Elevation Myocardial Infarction.

Int Heart J 2021 ;62(6):1230-1234

Department of Cardiology, Sakurakai Takahashi Hospital.

During the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, patients with ST-elevation myocardial infarction (STEMI) should be treated as possibly infected individuals. Therefore, more time is considered necessary to conduct primary percutaneous coronary intervention (PCI). In this study, we sought to evaluate the impact of the SARS-CoV-2 pandemic on primary PCI for STEMI. Read More

View Article and Full-Text PDF
January 2021

High Human Antimicrobial Peptide LL-37 Level Predicts Lower Major Adverse Cardiovascular Events after an Acute ST-Segment Elevation Myocardial Infarction.

J Atheroscler Thromb 2021 Dec 1. Epub 2021 Dec 1.

Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College.

Aims: We previously associated acute ST-elevation myocardial infarction (STEMI) with decreased plasma LL-37 levels. Therefore, this study investigated whether plasma LL-37 levels could predict ischemic cardiovascular events in patients after STEMI.

Methods: We prospectively collected peripheral plasma samples and clinical and laboratory data from consecutive patients who presented with STEMI and underwent primary percutaneous coronary intervention at Fuwai Hospital between April and November 2017. Read More

View Article and Full-Text PDF
December 2021

Coronary Artery Disease Without Standard Cardiovascular Risk Factors.

Am J Cardiol 2021 Nov 28. Epub 2021 Nov 28.

Department of Cardiology, Mitsubishi Kyoto Hospital, Kyoto, Japan.

Recently, one observational study showed that patients with ST-segment elevation myocardial infarction (STEMI) without standard cardiovascular risk factors were associated with increased mortality compared with patients with risk factors. This unexpected result should be evaluated in other populations including those with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) and chronic coronary syndrome (CCS). Among 30,098 consecutive patients undergoing first coronary revascularization in the CREDO-Kyoto PCI/CABG (Coronary Revascularization Demonstrating Outcome Study in Kyoto Percutaneous Coronary Intervention/Coronary Artery Bypass Grafting) registry cohort-2 and 3, we compared clinical characteristics and outcomes between patients with and without risk factors stratified by their presentation (STEMI n = 8,312, NSTE-ACS n = 3,386, and CCS n = 18,400). Read More

View Article and Full-Text PDF
November 2021

Profile and management of acute coronary syndromes at primary- and secondary-level healthcare facilities in Cape Town.

Cardiovasc J Afr 2021 Nov 16;32:1-7. Epub 2021 Nov 16.

Division of Cardiology, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa; Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa; Cape Heart Institute, University of Cape Town, Cape Town, South Africa.

Background: Little is known about the clinical profile and management of patients with acute coronary syndromes (ACS) in the South African public sector.

Methods: We conducted a retrospective study of patients presenting with ACS to a secondary-level healthcare facility in Cape Town during a one-year period to study the clinical profile and management of these patients.

Results: Among the 214 patients in this cohort, 48 (27. Read More

View Article and Full-Text PDF
November 2021

Evolutionary de Winter pattern: from STEMI to de Winter ECG-a case report.

ESC Heart Fail 2021 Nov 30. Epub 2021 Nov 30.

Department of Cardiology, Shunde Hospital, Southern Medical University (The First People's Hospital of Shunde), Shunde, Foshan, China.

The de Winter electrocardiography (ECG) pattern is a sign that implies proximal left anterior descending coronary artery occlusion in patients with chest pain. We report a case of a 34-year-old man with a history of smoking who presented to the local emergency department with a 49 min history of chest pain. The first ECG of the patient indicated that ST-segment elevation was noted in the lead V2-V4; 57 min later, a second ECG revealed a typical de Winter syndrome when the patient was transferred to the emergency chest pain centre of our hospital. Read More

View Article and Full-Text PDF
November 2021

Association of plasma interleukin-6 with infarct size, reperfusion injury, and adverse remodelling after ST-elevation myocardial infarction.

Eur Heart J Acute Cardiovasc Care 2021 Nov 25. Epub 2021 Nov 25.

Departement of Internal Medicine III, Cardiology and Angiology, Medical University of Innsbruck, Anichstrasse 35, Innsbruck A-6020, Austria.

Aims : Little is known about the clinical relevance of interleukin (IL)-6 in patients with acute ST-elevation myocardial infarction (STEMI). This study examined the possible associations of plasma IL-6 concentrations with infarct size (IS), reperfusion injury and adverse left ventricular remodelling (LVR), in STEMI patients treated with primary percutaneous coronary intervention (PCI).

Methods And Results: We prospectively included 170 consecutive STEMI patients (median age 57 years, 14% women) treated with primary PCI between 2017 and 2019. Read More

View Article and Full-Text PDF
November 2021

Incidence, clinical presentation, management, and outcome of acute pericarditis and myopericarditis.

Eur Heart J Acute Cardiovasc Care 2021 Nov 28. Epub 2021 Nov 28.

Department of Cardiology, Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, University of Basel, Petersgraben 4, CH-4031 Basel, Switzerland.

Aims: Little is known about the epidemiology, clinical presentation, management, and outcome of acute pericarditis and myopericarditis.

Methods And Results: The final diagnoses of acute pericarditis, myopericarditis, and non-ST-segment elevation myocardial infarction (NSTEMI) of patients presenting to seven emergency departments in Switzerland with acute chest pain were centrally adjudicated by two independent cardiologists using all information including serial measurements of high-sensitivity cardiac troponin T. The overall incidence of pericarditis and myopericarditis was estimated relative to the established incidence of NSTEMI. Read More

View Article and Full-Text PDF
November 2021

The effects of synthetic cannabinoids on the cardiovascular system: A case-control study.

Turk J Emerg Med 2021 Oct-Dec;21(4):198-204. Epub 2021 Oct 29.

Department of Emergency Medicine, Gaziosmanpaşa Training and Research Hospital, Istanbul, Turkey.

Objectives: Limited clinical studies have investigated the effects of synthetic cannabinoids (SCs) on the cardiovascular system (CVS). The aim of this study was to evaluate the effects of SCs on the CVS.

Methods: The patient group of this single-center, prospective, case-control study consisted of adult patients presenting to the emergency department (ED) with symptoms of SC use. Read More

View Article and Full-Text PDF
October 2021

The influence of biological age and sex on long-term outcome after percutaneous coronary intervention for ST-elevation myocardial infarction.

Am J Cardiovasc Dis 2021 25;11(5):659-678. Epub 2021 Oct 25.

William Harvey Research Institute, Barts & The London School of Medicine & Dentistry, Queen Mary University of London London, United Kingdom.

Background: Outcome following ST-segment elevation myocardial infarction (STEMI) is thought to be worse in women than in age-matched men. We assessed whether such differences occur in the UK Pan-London dataset and if age, and particularly menopause, influences upon outcome.

Methods: We undertook an observational cohort study of 26,799 STEMI patients (20,633 men, 6,166 women) between 2005-2015 at 8 centres across London, UK. Read More

View Article and Full-Text PDF
October 2021

The impact of the COVID-19 pandemic on the delivery of primary percutaneous coronary intervention in STEMI.

Am J Cardiovasc Dis 2021 25;11(5):647-658. Epub 2021 Oct 25.

St Bartholomew's Hospital, Barts Health NHS Trust London EC1A 7BE, UK.

Objectives: The clinical environment has been forced to adapt to meet the unprecedented challenges posed by the COVID-19 pandemic. Intensive care facilities were expanded in anticipation of the pandemic where the consequences include severe delays in elective procedures. Emergent procedures such as Percutaneous Coronary Intervention (PCI) in acute myocardial infarction (AMI) in which delays in timely delivery have well established adverse prognostic effects must also be explored in the context of changes in procedure and public behaviour associated with the COVID-19 pandemic. Read More

View Article and Full-Text PDF
October 2021

Trends and differences in management and outcomes of cardiac arrest in underweight and obese acute myocardial infarction hospitalizations.

Am J Cardiovasc Dis 2021 25;11(5):576-586. Epub 2021 Oct 25.

Section of Cardiovascular Medicine, Department of Medicine, Wake Forest University School of Medicine High Point, North Carolina, USA.

The influence of weight on in-hospital events of acute myocardial infarction complicated with cardiac arrest (AMI-CA) is understudied. To address this, we utilized the National Inpatient Sample database (2008-2017) to identify adult AMI-CA admissions and categorized them by BMI into underweight, normal weight, and overweight/obese groups. The outcomes of interest included differences in in-hospital mortality, use of invasive therapies, hospitalization costs, and hospital length of stay across the three weight categories. Read More

View Article and Full-Text PDF
October 2021